✦ LIBER ✦

TCT-34: Everolimus-Eluting Stent Versus Sirolimus- and Paclitaxel-Eluting Stents in Real-Life Practice: Pooled Analysis From the XAMI, COMPARE and APPENDIX-AMI Trials

Book ID: 119270831
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 71 KB
Volume: 58
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2011.10.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Lesion Length and Vessel Size

Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials

✍ Bimmer E. Claessen; Pieter C. Smits; Dean J. Kereiakes; Helen Parise; Martin Fah 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 503 KB

An everolimus-eluting stent versus a pac

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

✍ Antonio L. Bartorelli; Patrick W. Serruys; Karine Miquel-Hébert; Shui Yu; Wes Pi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

TCT-353 Long-Term Outcomes of Biodegrada

TCT-353 Long-Term Outcomes of Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents in Patients with Diabetes: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 4 and LEADERS Randomized Trials

✍ Lamin King; Antoinette de Waha; Lamin King; Robert Byrne; Salvatore Cassese; Adn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 127 KB